Abbott FreeStyle Libre 2 integrated continuous glucose monitoring system will now be available to US Medicare beneficiaries with diabetes, the company announced on 1 September.
Abbott said it has now secured partial or full reimbursement for its entire FreeStyle Libre portfolio in 37 countries, including...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?